Caladrius Biosciences Inc (NASDAQ:CLBS)

4.01
Delayed Data
As of May 24
 0.00 / 0.00%
Today’s Change
2.63
Today|||52-Week Range
6.35
+14.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-55.5M-81.0M-33.3M22.2M
 
 
 
 
 
Depreciation2.2M2.7M2.7M372.0K
 
 
 
 
 
Total Other Cash Flow8.2M53.9M3.2M-48.0M
 
 
 
 
 
Funds From Operations-45.2M-41.7M-27.2M-26.0M
 
 
 
 
 
Funds From/For Other Operating Expenses1.7M-2.5M-3.6M-5.1M
 
 
 
 
 
Net Cash Flow - Operating Activities-46.9M-39.3M-23.7M-20.9M
 
 
 
 
 
 
InvestingIncrease In Investments-8.0M-6.1M0.00-60.2M
 
 
 
 
Decrease In Investments913.0K13.1M0.0033.9M
 
 
 
 
Capital Expenditures-3.7M-3.2M-2.8M-135.3K
 
 
 
 
 
Fixed Asset Disposal50.9K0.00--74.6M
 
 
 
Net Assets From Acquisitions --0.000.00-6.7M
 
 
Other Investing - Uses0.000.000.00-188.8K
 
 
Net Cash Flow Investing-10.7M3.8M-2.8M41.3M
 
 
 
 
 
 
FinancingShort Term Borrowings-3.2M0.00----
 
 
Long Term Borrowings16.3M1.1M979.6K401.0K
 
 
 
 
 
Long Term Debt Reduction-1.1M-954.3K-11.0M-6.6M
 
 
 
 
 
Net Proceeds Stock Sale18.7M36.5M11.6M5.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing0.000.0019.4M--
 
 
Other Uses - Financing0.000.0072.0K431.9K
 
 
 
Net Cash Flow - Financing30.7M36.6M20.9M-931.8K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-27.0M1.1M-5.6M19.5M